BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38697682)

  • 1. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
    Vollmer S; Olsson K
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38697682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced osteomalacia: experience from a South American academic center.
    González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
    Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
    Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
    Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypophosphataemia-inducing mesenchymal tumour in the foot.
    Bauer C; Brücker R; Bützberger S; Schmid C
    BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22778109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
    Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
    Ryhänen EM; Schalin-Jäntti C; Matikainen N
    Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
    Westerberg PA; Linde T; Ljunggren O
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
    [No Abstract]   [Full Text] [Related]  

  • 13. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
    Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogenic osteomalacia and its symptoms: hypophosphatemia, bone pain and pathological fractures].
    Kaniuka-Jakubowska S; Biernat W; Sworczak K
    Postepy Hig Med Dosw (Online); 2012 Aug; 66():554-67. PubMed ID: 22922156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity].
    Ovchinnikov AY; Khon EM; Bakotina AV; Miroshnichenko NA; Gronskaia SA; Belaya ZE
    Vestn Otorinolaringol; 2023; 88(6):91-96. PubMed ID: 38153899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging case of tumour-induced osteomalacia.
    Kumar P; Jadhav DV; Ravat SH; Jain N
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rickets/Osteomalacia. Diagnosis of tumor-induced osteomalacia.].
    Koga M; Ito N
    Clin Calcium; 2018; 28(10):1351-1357. PubMed ID: 30269117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.